For Patients | Page 4
FDA Commissioner Releases Statement Highlighting Plans for Rare Disease Research
Researcher at the Feinstein Institute Receives Grants from DOD and NIH to Study HHT
Marquette University and Harmony 4 Hope Honor Rare Disease Day
The Importance of Researcher Involvement in the Rare Disease Community
Discussing Shire's Rare Disease Pipeline with Hartmann Wellhoefer, M.D.
Teva Announces Release of New Treatment for Wilson's Disease
IFFGD Will Participate in Rare Disease Day to Support Rare Digestive Disease Patients
A Sense of Urgency in Sanfilippo Therapy Development
Are Gaucher Disease and Parkinsons Linked?
New Hemophilia B Treatment Now Available in the United States
Sanofi Presents Safety Data from Phase 1/2 in Pompe
Amplify Hope Study Educates Families on Crowdfunding for Genetic Testing
ORDI Sponsors Race for 7 Event in Washington D.C.
CHLA Takes On Trial of Potential Stem Cell Procedure in Treating HLHS
A Rare Disease Day Timeline [Infographic]
<< Prev Page
Next Page >>
MOST POPULAR ARTICLES
Q&A with Hartmann Wellhoefer, Shire's VP and Head of Medical Affairs; Rare Diseases & Internal Medicine
Neuroblastoma Treatment Granted Orphan Drug Designation
Galinpepimut-S Safe and Effective in Multiple Myeloma
Nintedanib Gets Fast Track Designation for Treatment of Systemic Sclerosis
STRATEGIC ALLIANCE PARTNERSHIP PROGRAM >
Familial Chylomicronemia Syndrome
MJH ASSOCIATES >
Specialty Pharmacy Times
Terms & Conditions
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.